KPTI · CIK 0001503802 · operating
Karyopharm Therapeutics Inc. (KPTI) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $185 million, Karyopharm Therapeutics Inc. is a micro-cap company. The stock currently trades at $9.60, up 2.02% today, with a 52-week range of $3.51–$10.99.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-17.93 | $-17.93 | -1828.0% | |
| 2024 | $-0.93 | $-0.63 | +25.6% | |
| 2023 | $-1.25 | $-1.25 | +38.1% | |
| 2022 | $-2.02 | $-2.02 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-13 | 0001193125-26-049397 | SEC ↗ |
| 2024-12-31 | 2025-02-19 | 0000950170-25-022765 | SEC ↗ |
| 2023-12-31 | 2024-02-29 | 0000950170-24-022650 | SEC ↗ |
| 2022-12-31 | 2023-02-17 | 0000950170-23-003129 | SEC ↗ |
| 2021-12-31 | 2022-03-01 | 0000950170-22-002548 | SEC ↗ |
| 2020-12-31 | 2021-02-24 | 0001193125-21-054811 | SEC ↗ |
| 2019-12-31 | 2020-02-26 | 0001193125-20-049115 | SEC ↗ |
| 2018-12-31 | 2019-02-28 | 0001193125-19-057610 | SEC ↗ |
| 2017-12-31 | 2018-03-15 | 0001193125-18-084024 | SEC ↗ |
| 2016-12-31 | 2017-03-16 | 0001193125-17-084396 | SEC ↗ |
| 2015-12-31 | 2016-03-15 | 0001193125-16-505181 | SEC ↗ |
| 2014-12-31 | 2015-03-13 | 0001193125-15-091264 | SEC ↗ |